Adults with attention deficit hyperactivity disorder (ADHD) can benefit from evidence-based treatments, according to a new study published in the journal Lancet Psychiatry. The study found that stimulant medications and atomoxetine were more effective than placebos in reducing core symptoms of ADHD, such as inattention, hyperactivity, and impulsivity.
The researchers analyzed 113 trials involving nearly 15,000 adult participants with ADHD and found that only stimulants and atomoxetine yielded better results than a placebo. However, the study highlights gaps in knowledge about effective treatments for adults with ADHD.
Dr. Samuele Cortese, lead author of the study, emphasized that “ADHD is a serious condition that requires evidence-based treatment.” The study suggests that adults with ADHD should discuss their treatment options with a healthcare provider to find the best combination of medication and non-pharmacological therapies.
While the study has limitations, including short-term trial durations, it provides valuable insights into effective treatments for adult ADHD. Experts stress the need for more long-term studies on various types of treatments and combinations of them.
In addition to medication, non-pharmacological treatments like cognitive behavioral therapy (CBT) can help adults with ADHD manage symptoms and improve quality of life. However, more research is needed to understand how these treatments work best in combination with medication.
The study’s findings emphasize the importance of personalized treatment approaches for adults with ADHD. By working with a healthcare provider to develop a tailored treatment plan, individuals with ADHD can better manage their symptoms and achieve improved well-being.
Source: https://edition.cnn.com/2024/12/17/health/adhd-adult-treatments-study-wellness/index.html